Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European respiratory journal 2015-12, Vol.46 (6), p.1563-1576
Hauptverfasser:	Getahun, Haileyesus, Matteelli, Alberto, Abubakar, Ibrahim, Aziz, Mohamed Abdel, Baddeley, Annabel, Barreira, Draurio, Den Boon, Saskia, Borroto Gutierrez, Susana Marta, Bruchfeld, Judith, Burhan, Erlina, Cavalcante, Solange, Cedillos, Rolando, Chaisson, Richard, Chee, Cynthia Bin-Eng, Chesire, Lucy, Corbett, Elizabeth, Dara, Masoud, Denholm, Justin, de Vries, Gerard, Falzon, Dennis, Ford, Nathan, Gale-Rowe, Margaret, Gilpin, Chris, Girardi, Enrico, Go, Un-Yeong, Govindasamy, Darshini, D Grant, Alison, Grzemska, Malgorzata, Harris, Ross, Horsburgh, Jr, C Robert, Ismayilov, Asker, Jaramillo, Ernesto, Kik, Sandra, Kranzer, Katharina, Lienhardt, Christian, LoBue, Philip, Lönnroth, Knut, Marks, Guy, Menzies, Dick, Migliori, Giovanni Battista, Mosca, Davide, Mukadi, Ya Diul, Mwinga, Alwyn, Nelson, Lisa, Nishikiori, Nobuyuki, Oordt-Speets, Anouk, Rangaka, Molebogeng Xheedha, Reis, Andreas, Rotz, Lisa, Sandgren, Andreas, Sañé Schepisi, Monica, Schünemann, Holger J, Sharma, Surender Kumar, Sotgiu, Giovanni, Stagg, Helen R, Sterling, Timothy R, Tayeb, Tamara, Uplekar, Mukund, van der Werf, Marieke J, Vandevelde, Wim, van Kessel, Femke, van't Hoog, Anna, Varma, Jay K, Vezhnina, Natalia, Voniatis, Constantia, Vonk Noordegraaf-Schouten, Marije, Weil, Diana, Weyer, Karin, Wilkinson, Robert John, Yoshiyama, Takashi, Zellweger, Jean Pierre, Raviglione, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Antitubercular Agents - therapeutic use Coinfection - epidemiology Comorbidity Disease Management Drug Users Emigrants and Immigrants Evidence-Based Medicine Health Personnel HIV Infections - epidemiology Homeless Persons Human immunodeficiency virus Humans Interferon-gamma Release Tests Isoniazid - therapeutic use Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - therapy Latent Tuberculosis - diagnosis Latent Tuberculosis - drug therapy Latent Tuberculosis - epidemiology Lentivirus Mass Screening Mycobacterium tuberculosis Practice Guidelines as Topic Prisoners Public Health Radiography, Thoracic Renal Dialysis Rifampin - analogs & derivatives Rifampin - therapeutic use Risk Assessment Silicosis - epidemiology Substance-Related Disorders - epidemiology Transplant Recipients Tuberculin Test Tumor Necrosis Factor-alpha - antagonists & inhibitors World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of
ISSN:	0903-1936 1399-3003
DOI:	10.1183/13993003.01245-2015